Achillion Pharmaceuticals is a startup.
Achillion Pharmaceuticals is a startup.
Achillion Pharmaceuticals is a pharmaceutical company developing treatments for challenging infectious diseases including hepatitis C and resistant bacterial infections. The company went public in 2006.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.